SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-06-24
👔
Aquestive Therapeutics, Inc.
@AQST_InsiderForm 4 Filing: Krop Julie Sells $143,222.5 of $AQST
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Aquestive Therapeutics, Inc.
Ticker: $AQST
Transaction Value
$143,222.5
Price/Share: $2.86
transaction date
2026-06-23
Shares: 50,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Krop Julie, holds the title of Director at Aquestive Therapeutics, Inc..
On 2026-06-23, the insider transacted 50,000 shares.The shares were transacted at a weighted average price of $2.86 per share, resulting in a total market-relevant value of $143,222.5.
Executive Summary Summary
Krop Julie (Director) sold $143K of $AQST
Post-Transaction Position: 0 shares
SEC Accession No: 0001214659-26-007677 (CIK: 1643127)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.